Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Finasteride and Nandrolone Interaction: Avoid | Peptide Database

Compound Profiles Finasteride 5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, an

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Finasteride

5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH

Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).

Nandrolone

Anabolic-Androgenic Steroid | Joint & Collagen Support

Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Finasteride with Nandrolone?

Combining Finasteride with Nandrolone is not recommended. DO NOT combine. This is one of the most misunderstood drug interactions in anabolic steroid use. Nandrolone is normally converted by 5-alpha reductase to dihydronandrolone (DHN), a much weaker androgen that is protective in androgen-sensitive tissues. Finasteride (and dutasteride) block this conversion, preventing nandrolone from being reduced to the weaker DHN. This leaves the more androgenic parent compound -- nandrolone itself -- to act unopposed on hair follicles, skin, and the prostate. The result is the exact opposite of the intended effect: hair loss is WORSENED, not prevented. Acne and prostate stimulation also increase. Unlike testosterone, where finasteride reduces androgenic load by blocking conversion to the more potent DHT, with nandrolone the 5-alpha reduced metabolite (DHN) is the weaker compound, so blocking 5-alpha reductase removes a protective pathway. This applies equally to finasteride and dutasteride. If you are using nandrolone and are concerned about hair loss, the solution is to lower the nandrolone dose or discontinue it -- not to add a 5-alpha reductase inhibitor.

Is Finasteride and Nandrolone safe together?

This combination carries significant risk. DO NOT combine. This is one of the most misunderstood drug interactions in anabolic steroid use. Nandrolone is normally converted by 5-alpha reductase to dihydronandrolone (DHN), a much weaker androgen that is protective in androgen-sensitive tissues. Finasteride (and dutasteride) block this conversion, preventing nandrolone from being reduced to the weaker DHN. This leaves the more androgenic parent compound -- nandrolone itself -- to act unopposed on hair follicles, skin, and the prostate. The result is the exact opposite of the intended effect: hair loss is WORSENED, not prevented. Acne and prostate stimulation also increase. Unlike testosterone, where finasteride reduces androgenic load by blocking conversion to the more potent DHT, with nandrolone the 5-alpha reduced metabolite (DHN) is the weaker compound, so blocking 5-alpha reductase removes a protective pathway. This applies equally to finasteride and dutasteride. If you are using nandrolone and are concerned about hair loss, the solution is to lower the nandrolone dose or discontinue it -- not to add a 5-alpha reductase inhibitor. Consult a healthcare professional before combining.

What are the interactions between Finasteride and Nandrolone?

DO NOT combine. This is one of the most misunderstood drug interactions in anabolic steroid use. Nandrolone is normally converted by 5-alpha reductase to dihydronandrolone (DHN), a much weaker androgen that is protective in androgen-sensitive tissues. Finasteride (and dutasteride) block this conversion, preventing nandrolone from being reduced to the weaker DHN. This leaves the more androgenic parent compound -- nandrolone itself -- to act unopposed on hair follicles, skin, and the prostate. The result is the exact opposite of the intended effect: hair loss is WORSENED, not prevented. Acne and prostate stimulation also increase. Unlike testosterone, where finasteride reduces androgenic load by blocking conversion to the more potent DHT, with nandrolone the 5-alpha reduced metabolite (DHN) is the weaker compound, so blocking 5-alpha reductase removes a protective pathway. This applies equally to finasteride and dutasteride. If you are using nandrolone and are concerned about hair loss, the solution is to lower the nandrolone dose or discontinue it -- not to add a 5-alpha reductase inhibitor. This assessment has 95% confidence and is based on documented research data.

How should I time Finasteride and Nandrolone?

Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and Nandrolone has a half-life of ~6-12 days (decanoate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Primary mechanism activating dormant muscle satellite cells which fuse to damaged fibers. Increases proliferative lifespan in younger muscle progenitor cells. Increases activated satellite cell fusion capacity supporting repair and hypertrophy. Animal studies suggest improved Achilles tendon injury outcomes. Rabbit models demonstrated faster healing via osteoblast regulation. Research indicates potential for articular cartilage injury models. Naturally upregulated after mechanical stress; supplementation may enhance processes. Localized injection near injury sites supports targeted tissue repair.

Source: peptide-db.com ↗

Research Indications

Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation. May support overall urinary tract function and tissue health. Potential benefits for pelvic tissue health and function. Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue. May help alleviate symptoms associated with benign prostatic hyperplasia. Part of comprehensive bioregulator protocols addressing age-related urogenital changes. Supports cellular regeneration in urinary and reproductive tissues.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Teriparatide is administered as a once-daily subcutaneous injection, typically in the thigh or abdomen. It comes in pre-filled pen devices (Forteo) containing a 28-day supply. Treatment is typically limited to 2 years due to theoretical bone cancer risk from long-term use (seen only in rats at high doses). Osteoporosis treatment 20 mcg Once daily SubQ (thigh or abdomen)

Source: peptide-db.com ↗
Side effects

What's the biggest side effect of ondansetron?

Constipation is the most common ongoing side effect because 5-HT3 blockade reduces gut motility. At 4-8 mg as-needed, this is usually mild and transient. With daily or frequent dosing, constipation becomes more pronounced and may require management with increased fiber, hydration, or occasional use of a stool softener or osmotic laxative.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →